steviolbioside
Small moleculeexperimental
Stevioside is a glycoside derived from the stevia plant, which can be used as a sweetener. — Wikipedia
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01757990)
Timeline
Indications
Mechanism of action
- Human immunodeficiency virusINHIBITOR
Human immunodeficiency virus inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C=C1C[C@@]23CC[C@H]4[C@@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2CC[C@]1(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C3- Mol. weight
- 804.88 g/mol
- Lipinski Ro5
- 3 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaStevioside ↗
- ChEMBLCHEMBL444122 ↗
Also known as
- steviolbioside
- stevioside
- stevioside
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05852145 | Phase 1/Phase 2 (Phase 2) | Oct 31, 2023 | Government of Mexico |
| NCT03680482 | N/A | Jan 11, 2016 | University of Chile |
| NCT01757990 | Phase 2 | Mar 1, 2012 | University of Milan, University of Sassari |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Mexico | Government | 1 | 1 | 1 | 2023 |
| University of Chile | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Milan | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Sassari | Academic/Hospital | 1 | 1 | 1 | 2012 |
4 organizations
Page 1 / 1